Curanex Pharmaceuticals Inc Common Stock

NASDAQ: CURX · Healthcare · Biotechnology

PublicHQ Jericho, NY · NassauCIK 0002025942Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 63DQ —GM —SS 23

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, Altman-Z · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$4.2M

Employees

Market cap

$7.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$4.2M-$4.2M2025

Operating income-$4.2M-$4.2M2025

Total assets$11.6M$11.6M2025

Liabilities$361.0k$361.0k2025

Equity$11.2M$11.2M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Curanex Pharmaceuticals Inc Common Stock earned -$4.2M in FY2025 net income.

Peers · Healthcare

Comprehensive Healthcare Systems, Inc.42D INNOCAN PHARMA Corp59C cbdMD, Inc.50D BioCorRx Inc.44D

Neighbors

Nassau →

Kimco Realty Corporation$2.1B67B Broadridge Financial Solutions, Inc.$6.9B77B+Flagstar Financial, Inc.$27.0M41D Veeco Instruments Inc.$664.3M71B Getty Realty Corp.$221.7M76B+Global Industrial Co$1.4B75B+

Key facts

CEOJun Liu

SectorHealthcare

IndustryBiotechnology

HeadquartersJericho, NY

ExchangeNASDAQ: CURX

Employees6

IPO date2025-08-26

Latest filings

8-K2026-05-14 10-Q2026-05-14 8-K2026-05-07 8-K2026-04-02 10-K2026-03-30 8-K2026-03-06 8-K2026-01-05 10-Q2025-11-17

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.